Minimal impact of selective susceptibility reporting on the use of piperacillin-tazobactam for Escherichia coli and Klebsiella bacteremia

Selective cascade reporting of antibiotic susceptibilities did not have a significant impact on de-escalation from piperacillin-tazobactam (PT), duration of PT use, length of stay, or rates of acute kidney injury and Clostridioides difficile infection in patients with positive monomicrobial blood cu...

Full description

Saved in:
Bibliographic Details
Published inInfection control and hospital epidemiology Vol. 42; no. 10; pp. 1272 - 1274
Main Authors Zahlanie, Yorgo, Hall, Brenton C, Wei, Wenjing, Mang, Norman S, Ortwine, Jessica K, Anderson, Shelby, Morgan, Kristi, Guzman, Tamara P, Hynan, Linda S, Prokesch, Bonnie C
Format Journal Article
LanguageEnglish
Published United States Cambridge University Press 01.10.2021
Subjects
Anti-Bacterial Agents - therapeutic use
Antibiotics
Antimicrobial agents
Bacteremia - drug therapy
Clinical outcomes
Concise Communication
Creatinine
E coli
Escherichia coli
Feedback
Humans
Intervention
Kidneys
Klebsiella
Patients
Piperacillin, Tazobactam Drug Combination
United States > US
Online AccessGet full text

Cover

More Information
Summary:Selective cascade reporting of antibiotic susceptibilities did not have a significant impact on de-escalation from piperacillin-tazobactam (PT), duration of PT use, length of stay, or rates of acute kidney injury and Clostridioides difficile infection in patients with positive monomicrobial blood cultures with either Escherichia coli or Klebsiella spp.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0899-823X
1559-6834
DOI:10.1017/ice.2020.1385